Next Dimension (NeD)
Retinal Spectral Imaging System
Company Overview
Snapshot
Founded in January 2005, Next Dimension (NeD) operates with 1–10 employees. The company is currently in a Pre-Funding stage.
Business overview
Next Dimension (NeD) is developing retinal imaging systems that utilize spectral imaging to map metabolic activity in the retina. This technology aims to provide early warnings for vision-threatening diseases such as diabetic retinopathy, AMD, and glaucoma, before the onset of noticeable anatomic tissue damage and vision loss. The system is designed for routine use in diagnosing and monitoring treatment for patients, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices for healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is Next Dimension (NeD)'s primary focus?
- Next Dimension (NeD) is focused on developing retinal imaging systems that use spectral imaging to map metabolic activity in the retina.
- What is the intended use of Next Dimension (NeD)'s technology?
- The company's technology is intended to provide an early warning for vision-threatening diseases like diabetic retinopathy, AMD, and glaucoma, and to be used for routine diagnosis and treatment monitoring.
- In which sector does Next Dimension (NeD) primarily operate?
- Next Dimension (NeD) operates within the Health Tech & Life Sciences sector, with a specific focus on Medical Devices and Diagnostics Devices.
- When was Next Dimension (NeD) founded?
- Next Dimension (NeD) was founded in January 2005.
- What is the current employee count for Next Dimension (NeD)?
- Next Dimension (NeD) currently has 1–10 employees.